• Home
  • Study Details
By physician referral or invitation only

Heart Failure Medication Study

This study is testing a medication called ziltivekmab to see if it can help people with heart failure.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Patricia Chang
Medicine - Cardiology

Study Type

Clinical or Medical
Interventional

Study Topics

Heart and Circulation

IRB Number

23-3276

ClinicalTrials.gov

NCT05636176

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research